摘要:
The invention relates to the use of S-adenosyl-L-methionine (SAMe) in the form of pharmaceutically acceptable salts in the preparation of injectable pharmaceutical compositions for the prevention and symptomatic treatment of intrahepatic cholestasis determined by total parenteral nutrition.
摘要:
On décrit une composition thérapeutique comprenant de la S-adénosyl-méthionine utile dans le traitement de la pancréatite et en tant qu'agent synergique de cyclosporine dans la prévention du rejet de greffe dans la transplantation du pancréas.
摘要:
New cytidine-diphosphocholine (CDP-choline) salts with long-alkyl chain sulphonic acids suitable for injectable pharmaceutical formulations, but more specifically for oral formulations. Said salts are prepared by a process comprising preparing an aqueous solution of basic CDP-choline, preparing an aqueous sulphonic acid solution, reacting these two solutions together to obtain the required salt, and recovering this salt with a high degree of purity.
摘要:
@ The present invention relates to new stable sulpho-adenosyl-L-methionine (SAMe) salts particularly suitable for parenteral use, their production process, and pharmaceutical compositions containing them as active principles. Said salts correspond to the general formula: where n can vary from 1 to 2 and m can vary from 3 to 12. The process for producing said salts consists of the following stages: a) enriching the starting yeast with SAMe; b) lysing the cells and recovering a solution rich in SAMe (cell lysate): c) prepurifying the cell lysate by ultrafiltration; d) passing the prepurified lysate through a column of weak acid ion exchange resin and eluting with the required disulphonic acid; e) passing the eluate of said column through a column of absorption resin and washing with the required disulphonic acid; f) concentrating the eluate of the latter column by reverse osmosis; g) drying the concentrated solution.